PANACEABIO / NSE / Biotechnology & Drugs
Panacea Biotec
1Y Price Trend
Key Information
Recommendations
Target High520.5
Target Low293.1
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk61.21
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Panacea Biotec Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Panacea Biotec Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Panacea Biotec Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Setbacks Markets Mojo
Panacea Biotec Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals Markets Mojo
Panacea Biotec Q4 FY26: Losses Return as Operating Margins Collapse Despite Revenue Growth Markets Mojo
Panacea Biotec narrows FY26 loss, passes over dividend scanx.trade
Panacea Biotec reports consolidated net profit of Rs 0.52 crore in the March 2026 quarter Business Standard
Panacea Biotec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 marketscreener.com
© SharekeyX | Rusaka Technologies 2024-2026